RATIONAL DRUG USE POLICY IN TURKEY

Slides:

Advertisements

Similar presentations

Donors Per Million Population

Advertisements

Confidential RISK ADVISORY SERVICES Latvijas Republikas Veselības ministrija Healthcare Information System Policy in Latvia Rinalds Muciņš, Ministry of.

REWARDING SYSTEM REALISTIC EXAMPLE (1) YOU 1 x 1 = 1 x 10 =10 1 x 1 = 1 x 3 =3 1 x 1 = 1 x 2.75 = x 1 = 1 x 2.50 =2.5 1 x 1 = 1 x 2 =2 1 x 1 = 1.

Calcul mental. 34,7 x 100 Diapositive n°1 34,7 x 100 = Diapositive n°1.

Alzheimer Bulgaria Association May 2012 Brussels 1Brussels, May 2012Association Alzheimer Bulgaria.

Data 14/10/08 Research Department National Accounts Coordination Health and education volume output in Brazil.

Foster families in Republic Macedonia Elka Todorova Ministry of Labor and Social Policy.

THE COMMONWEALTH FUND Figure 1. Health Insurance Coverage and Uninsured Trends Data: Analysis of the U.S. Census Bureau, Current Population Survey Annual.

A Perfect Storm Leads to Career Opportunities in the Medical Imaging Sciences.

1 Florida Department of Corrections Schedule VIIIB-2 (Required 10% Reduction Target) FY Senate Criminal & Civil Justice Appropriations November.

Specialist Registrar in Occupational Medicine

Implementing NICE guidance

Improving Use of Medicines - Where are we today? Kathleen A Holloway Regional Advisor Essential Drugs and Other Medicines World Health Organisation, South.

Diabetes in Idaho BRFSS 2009 Data collected from Behavioral Risk Factor Surveillance System Idaho Department of Health and Welfare, Division of.

Current situation at the insurance market in Hungary (system of covering ST by insurance companies, perspectives, suggested strategies) dr Choma Balázs.

THE COMMONWEALTH FUND Multinational Comparisons of Health Systems Data, 2013 David Squires The Commonwealth Fund November 2013.

Medication Management

Evaluation of a new Health Code requirement for discharging infectious tuberculosis patients from NYC hospitals Michelle M. Macaraig, MPH Assistant Director.

1 Exploration of Health Care Providers Behavior to Keep Their Revenues after Reduction of Payment Generosity --- A Case of Drug Payment in Taiwan Likwang.

Outstanding Care ~ People Focused Budget Consultation.

1 Division of Aging Services Dr. James J. Bulot year demonstration project funded by CMS Single largest investment in Medicaid Long Term Care 43.

3670 MAGUIRE BOULEVARD Tax Collector Proposal. Tax Collector Goals Find the best use of Taxpayer Dollars Consolidate the following Separate Operations.

For the Healthcare Provider

With support from the TB Alliance. 2 Vaccines $3,663,074 (36%) Pediatric TB R&D Investments by Research Category 2012 Total: $10,278,875 Basic Science$814,35.

Association between use of air-conditioning or fan and survival of elderly febrile patients: a prospective study George Theocharis, MD, Giannoula S. Tansarli,

IMPLEMENTATION OF HOSPITAL AUTONOMY: VIETNAM EXPERIENCES Health Strategy and Policy Institute - Vietnam.

Evaluation of the New Rural Cooperative Medical Scheme Outpatient Capitation Payment Reform in Qianjiang District of Chongqing, China Qu, Qian (1);  Sun,

Project Lazarus A community-wide response to managing pain.

SEPTEMBER 2011MASSACHUSETTS MEDICAID POLICY INSTITUTE DUAL ELIGIBLES IN MASSACHUSETTS: A PROFILE OF HEALTH CARE SERVICES AND SPENDING FOR NON-ELDERLY ADULTS.

A model of outhospital management of H1N1v influenza epidemic by SOS Doctors in Greece. Spyridon G. Barbas, MD, Theodore Spiropoulos, MD, George Peppas,MD,

1 STREAMLINING UTIs PROJECT 12 MONTH EVALUATION REPORT November 2010 Anna Rozario Clinical Redesign/Service improvement Unit.

Partial Products. Category 1 1 x 3-digit problems.

World Health Organization

1 Sep 15Fall 05 Standards in Medical Informatics Standards Nomenclature Terminologies Vocabularies.

Social Security Disability- insurance gap Increased health problems with decreased income Illness or injury Pre-existing condition/ uninsurable Health.

Mongolia Sub-national situation of patient safety D. Doljin, Director, Regional Diagnostic and Treatment Center for Eastern provinces (Dornod, Sukhbaatar.

Figure 1. Number of Tuberculosis Cases: California, California Department of Public Health, Tuberculosis Control Branch Number of Tuberculosis.

Overview of Drug Tracking System (ITS) in the Pharmacies of Ankara: Preliminary Research Yildirim, Fikri (1); Kockaya, Guvenc (1); Yildirim Ocal, Julide.

ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.

Reimbursement & Pricing in Turkey

Off-Label and Non-Licensed Endocrinology Medicine Use in Turkey: A Retrospective Analysis of Computer Records in the Turkish Ministry of Health Kockaya,

3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.

Healthcare Reforms and Pharmaceuticals Lessons from Turkey Prof. Dr. Mehtap Tatar Hacettepe University Faculty of Economics and Administrative Sciences.

Health Care In Latvia Current Situation And Challenges In the Future Ingrīda Circene Minister for Health of the Republic of Latvia Riga,

National Health Account in Taiwan: An update Chung-Fu Lan National Yang-Ming University Pi - Joen Lee Department of Health, ROC (Taiwan) Seoul, 5th SHA.

Economic Burden and Health Consequences of Antibiotic Resistance in Patients at a Tertiary Care Hospital, Vellore, South India Sujith J Chandy (1,2), Thomas.

Snapshot of IMS LifeLink Claims Database 10% Random Sample

Burçak Deniz DEDEOĞLU, MD. PhD. Head of Rational Drug Use Department Ministry of Health of Turkey General Directorate of Pharmaceuticals and Pharmacy RATIONAL.

Abstract Pattern of medicine use among in-patients in a tertiary health care setting using the WHO prescribing indicators Ehizokhale Peter Akhideno, Department.

Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.

T.C. SOCIAL SECURITY INSTITUTION DIRECTORATE GENERAL of UNIVERSAL HEALTH INSURANCE DEPARTMENT of PHARMACY and PHARMACEUTICALS RATIONAL DRUG USE - SOCIAL.

Drug & Poison Control center

WHO PRESCRIBING INDICATORS (1991 – 1995) TRENDS AND PERSPECTIVES IN AN OUTPATIENT HEALTH CARE FACILITY IN BENIN CITY, NIGERIA. 1 Isah AO, 2 Isah EC, 3.

The Effects of Managerial Intervention on Drug Prescribing Patterns at King Chulalongkorn Memorial Hospital Limpanathikul W, Wangsaturaka D, Nantawan P,

E-Transformation Turkey & National Health Information Systems Datasel Bilgi Sistemleri A.S, Turkey 1.

Background: Tomson G 1, Kronvall G 2, Chuc NTK 3, Binh NT 4, Chalker J 5, Falkenberg T 1. 1 Div. International Health (IHCAR), Dep. Public Health Sciencies,

Impacts of Direct Fee-For- Service Payment Insurance on Access and Use of Drug: An Interrupted Time Series Study on Diabetic Care Inthira Kanchanaphibool,

Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.

Al Noor Drug Store Amman- Jordan Established in 2001.

National Hospital Care Survey (NHCS) Acute Coronary Syndrome Study.

Click to begin. Click here for Bonus round OIG Issues Medicare & Medicaid General 100 Point 200 Points 300 Points 400 Points 500 Points 100 Point 200.

Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Sripairoj A, Liamputtong P, Harvey K La Trobe University, Australia.

Evaluating Sepsis Guidelines and Patient Outcomes

ABSTRACT Problem statement: The Lao PDR National Drug Policy (NDP) Program, implemented by the Ministry of Health supported by the Swedish International.

Ministry of Health Montenegro ERASMUS+ KA2 PROJECT:

Abstract Impact of the National Healthcare Reform on Prescribing Patterns of Promotional Targeted Drugs among Thai Physicians Layton MR*, Chadbunchachai.

PH Dung, NTK Chuc and Dennis Ross Degan

Drug Policy in the Czech Republic

Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan

Percentage of all inpatient episodes for selected cardiovascular conditions, by sex and country of the UK, 2012/2013. Percentage of all inpatient episodes.

Presentation transcript:

RATIONAL DRUG USE POLICY IN TURKEY Dedeoglu, Burcak Deniz; Celik, Hatice Demet; Akbulat, Akif; Akar, Halil; Kerman, Saim.

Abstract RATIONAL DRUG USE POLICY IN TURKEY Burcak Deniz Dedeoglu, Hatice Demet Celik, Akif Akbulat, Halil Akar, Saim Kerman Ministry of Health of Turkey, Turkey Studies were conducted by Ministry of Health and many different associations on the issue about “Rational drug use” in Turkey. Institutional activities regarding this issue has been initiated on 12.10.2010 by the Ministry of Health of TURKEY with the establishment of rational drug use department under the the department of pharmacoeconomics. Among the main purposes of the Rational Drug Use Department; generalizing the principles of rational drug use all over the TURKEY and performing campaigns with this aim can be stressed. In order to make suggestions to Social Security Institution (SSI) about the issues of; considering the principles of rational drug use while devoloping the repayment (reimbursement) plans, obtaining the education of the health staff on principles of rational drug use, evaluating the prescriptions according to principles of rational drug use, coordinating the publishment of the national guidelines for diagnosis and treatment and drug guideline periodically and measuring the awareness level of society and health staff about rational drug use. Based on the data taken from SSI, excluding the primary healthcare services, the number of patients applied to a healthcare service and invoices have been sent to SSI in 2008, 2009 and 2010 were 216.930.000, 247.142.000 and 230.112.000 (for first ten months of 2010) respectively, in Turkey. These numbers were classified as “outpatients”, “inpatients”, “others” and “daily” for months. In monthly distrubition perspective, the applications were higher in summer than winter. Total prescription number for workers, civil servants and green card owners in 2009 and 2010 (for first ten months of 2010) were 327.000.000 and 250.138.000 respectively and total prescription invoice number was 16.000 billion TL and 12.259 billion TL. while the average costs per prescription were 48.95 TL. and 49.01 TL, respectively. The expectation is, the rational drug use policy will reduce the total drug cost and increase the awareness of society and health staff about rational drug use.

Introduction Studies were conducted by Ministry of Health and many different associations on the issue about “Rational drug use” in Turkey. Institutional activities regarding this issue has been initiated on 12.10.2010 by the Ministry of Health of Turkey with the establishment of rational drug use department. Among the main purposes of the Rational Drug Use Department; generalizing the principles of rational drug use all over the Turkey and performing campaigns with this aim can be stressed. In order to make suggestions to Social Security Institution (SSI) about the issues of; considering the principles of rational drug use while devoloping the repayment (reimbursement) plans, obtaining the education of the health staff on principles of rational drug use, evaluating the prescriptions according to principles of rational drug use, coordinating the publishment of the national guidelines for diagnosis and treatment and drug guideline periodically and measuring the awareness level of society and health staff about rational drug use.

Objectives Evaluation the current situation about healthcare services and drugs by analaysing the data of SSI and IMS Institute for Healthcare Informatics. The number of patients applied to a healthcare services and invoice costs; the number of prescription taken from Pharmacy Prevision System and invoice costs; 2010 drug units and costs according to ATC (Anatomical Therapeutic Chemical) codes were analaysed.

Results 1 Application Number (x1000) Invoice Cost (x1000 TL) Mean Cost IC/AN (TL) 2008 210.930 13.771.434 63.48 2009 247.142 15.653.143 63.34 2010 277.634 18.488.386 66.59 2011 (first 5 months) 134.969 9.118.785 67.56 Table 1: The number of patients applied to a healthcare service, excluding the primary healthcare services, and invoice costs Ref: SSI Monthly Statistical Bulletin; Publication No:13 P.S.: Data are expanded than the abstract because of the new version of SSI Statistical Bulletin sssssssss

Results 2 Prescription Number (x1000) Invoice Cost (x1000 TL) Mean Cost IC/PN (TL) 2008 302.412 13.046.556 43.14 2009 327.001 16.005.392 48.95 2010 306.461 14.897.455 48.61 2011 (first 5 months) 148.561 6.537.442 44.01 Table 2: The number of prescription taken from Pharmacy Provision System and invoice costs Ref: SSI Monthly Statistical Bulletin; Publication No:13 P.S.: Data are expanded than the abstract because of the new version of SSI Statistical Bulletin

Units Year/10 (Absolute) Results 3 Units Year/10 (Absolute) A0 ALIMENTARY T.& METABOLISM 226.479.339 R0 RESPIRATORY SYSTEM 225.593.377 J0 SYSTEMIC ANTI-INFECTIVES 223.775.601 M0 MUSCULO-SKELETAL SYSTEM 215.060.221 N0 NERVOUS SYSTEM 190.285.791 C0 CARDIOVASCULAR SYSTEM 153.493.692 D0 DERMATOLOGICALS 85.449.907 B0 BLOOD + B.FORMING ORGANS 62.125.768 G0 G.U.SYSTEM & SEX HORMONES 54.282.589 S0 SENSORY ORGANS 45.532.429 V0 VARIOUS 38.377.213 H0 SYSTEMIC HORMONES 23.332.437 T0 DIAGNOSTIC AGENTS 8.162.516 K0 HOSPITAL SOLUTIONS 7.818.533 L0 ANTINEOPLAST+IMMUNOMODUL 5.242.349 P0 PARASITOLOGY 5.040.567 Table 3: Drug Units in 2010 acording to ATC code Ref: IMS Institute for Healthcare Informatics

Results 4 Table 4: Drug costs in 2010 acording to ATC code TL Year/10 (Absolute) J0 SYSTEMIC ANTI-INFECTIVES 2.215.529.632 A0 ALIMENTARY T.& METABOLISM 2.112.972.993 C0 CARDIOVASCULAR SYSTEM 1.817.350.371 R0 RESPIRATORY SYSTEM 1.670.760.391 N0 NERVOUS SYSTEM 1.613.233.082 L0 ANTINEOPLAST+IMMUNOMODUL 1.260.034.408 M0 MUSCULO-SKELETAL SYSTEM 1.142.104.150 G0 G.U.SYSTEM & SEX HORMONES 713.159.010 B0 BLOOD + B.FORMING ORGANS 631.879.716 D0 DERMATOLOGICALS 510.403.595 V0 VARIOUS 333.849.317 S0 SENSORY ORGANS 302.511.660 T0 DIAGNOSTIC AGENTS 230.520.845 H0 SYSTEMIC HORMONES 194.499.452 K0 HOSPITAL SOLUTIONS 29.833.434 P0 PARASITOLOGY 15.592.092 Table 4: Drug costs in 2010 acording to ATC code Ref: IMS Institute for Healthcare Informatics

Policy Implications & Conclutions Among the main purposes of the Rational Drug Use Department; generalizing the principles of rational drug use all over the Turkey and performing campaigns with this aim can be stressed. In order to make suggestions to Social Security Institution (SSI) about the issues of; considering the principles of rational drug use while devoloping the repayment (reimbursement) plans, obtaining the education of the health staff on principles of rational drug use, evaluating the prescriptions according to principles of rational drug use, coordinating the publishment of the national guidelines for diagnosis and treatment and drug guideline periodically and measuring the awareness level of society and health staff about rational drug use. The expectation is, the rational drug use policy will reduce the total drug cost and increase the awareness of society and health staff about rational drug use.